Samrat Pharmachem has informed that the Board of Directors of the Company at its meeting held today i.e., Thursday, February 10, 2022, has considered and took on record the attached Un-Audited Standalone Financial Results of the Company for the quarter ended December 31, 2021, which is enclosed along with the Limited Review Report of the Statutory Auditor of the Company. The meeting of the Board of Directors of the Company commenced at 14:30 hrs and concluded at 15:30 hrs.
The above information is a part of company’s filings submitted to BSE.
